NASDAQ · FTLF

FitLife Brands, Inc.

$9.67 -$0.58 (-5.66%) 1D After hours

Key Metrics

$96.26M
Market cap
P/E · TTM
Revenue · TTM
−$298.00K
Net income
EPS · TTM $-0.03
Dividend yield
Free cash flow
Beta · 1Y 0.29
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 13
    From its Feb 2 high, the share price fell 46%.

    Peak close $16.36 on Feb 2; trough close $8.88 on Apr 13. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -46%
  • Apr 2
    The stock moved -12.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 2
  • Apr 1
    The stock moved -14.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 1

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$96.26M
Enterprise value
Shares outstanding9.4M
52-wk range$8.67 – $20.98
Avg volume · 20D15.0K
Net cash
Book value / share$4.57
IndustryMedicinal Chemicals & Botanical Products
ExchangeNASDAQ
About FitLife Brands, Inc.
IPO dateSep 25, 2007
Employees81

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -0.7% · —

Financial Health

Current ratio1.52
Quick ratio0.49
Debt / equity
Debt / EBITDA
Net cash
Working capital$10.83M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings